27 Oct
Pharmaceutical company Merck and Hadassah University Hospital in Jerusalem launched CanceRNA, which aims to use messenger-RNA technology to treat cancer Regine Shevach, the head of Merck’s Innovative Technologies Enablement Centre in Israel, has always believed in collaborations. “In the past, projects usually happened within the same industry,” she said. “Today, however, things have […]
READ MOREHadassah UK © 2022 | w/creators with Web Studio Lab
Join our digital newsletter to stay in touch with the latest news from Hadassah UK